The role of coinfections in HIV epidemic trajectory and positive prevention
Open Access
- 24 August 2011
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 25 (13) , 1559-1573
- https://doi.org/10.1097/qad.0b013e3283491e3e
Abstract
Objectives: Recurrent or persistent coinfections may increase HIV viral load and, consequently, risk of HIV transmission, thus increasing HIV incidence. We evaluated the association between malaria, herpes simplex virus type 2 (HSV-2) and tuberculosis (TB) coinfections and their treatment on HIV viral load. Design: Systematic review and meta-analysis of the association of malaria, HSV-2 and TB coinfections and their treatment with HIV viral load. Methods: PubMed and Embase databases were searched to 10 February 2010 for studies in adults that reported HIV plasma and/or genital viral load by coinfection status or treatment. Meta-analyses were conducted using random-effects models. Results: Forty-five eligible articles were identified (six malaria, 20 HSV-2 and 19 TB). There was strong evidence of increased HIV viral load with acute malaria [0.67 log10 copies/ml, 95% confidence interval (CI) 0.15–1.19] and decreased viral load following treatment (−0.37 log10 copies/ml, 95% CI −0.70 to −0.04). Similarly, HSV-2 infection was associated with increased HIV viral load (0.18 log10 copies/ml, 95% CI 0.01–0.34), which decreased with HSV suppressive therapy (−0.28 log10 copies/ml, 95% CI −0.36 to −0.19). Active TB was associated with increased HIV viral load (0.40 log10 copies/ml, 95% CI 0.13–0.67), but there was no association between TB treatment and viral load reduction (log10 copies/ml −0.02, 95% CI −0.19 to 0.15). Conclusion: Coinfections may increase HIV viral load in populations where they are prevalent, thereby facilitating HIV transmission. These effects may be reversed with treatment. However, to limit HIV trajectory and optimize positive prevention for HIV-infected individuals pre-antiretroviral therapy, we must better understand the mechanisms responsible for augmented viral load and the magnitude of viral load reduction required, and retune treatment regimens accordingly.Keywords
This publication has 71 references indexed in Scilit:
- Effect of treating co-infections on HIV-1 viral load: a systematic reviewThe Lancet Infectious Diseases, 2010
- Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysisThe Lancet, 2010
- Long‐Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled TrialThe Journal of Infectious Diseases, 2010
- Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trialThe Lancet, 2010
- Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2New England Journal of Medicine, 2010
- Persistence of HIV-1 receptor–positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisitionNature Medicine, 2009
- Herpes Simplex Virus (HSV)–Suppressive Therapy Decreases Plasma and Genital HIV‐1 Levels in HSV‐2/HIV‐1 Coinfected Women: A Randomized, Placebo‐Controlled, Cross‐Over TrialThe Journal of Infectious Diseases, 2008
- Herpes Simplex Virus Type 2 Acquisition During Recent HIV Infection Does Not Influence Plasma HIV LevelsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesisProceedings of the National Academy of Sciences, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002